Learning From Agility, Partnership and Innovation During the Covid-19 Pandemic: A Perspective From Industry
Ana María Cárdenas, Celine Roger-Dalbert
Frontiers in Cellular and Infection Microbiology · 2022
doi:10.3389/fcimb.2022.838565 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Two years after the COVID-19 pandemic started, the world continues to adapt to the profound effects that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has had on our lives. As the global crisis took hold, many looked to the medical technology/device industry for guidance and solutions. All while the industry itself, was disrupting its own processes and activities. In order to evolve and deliver accelerated innovation the industry had to be agile, resilient and collaborative with the broader healthcare community and technology partners. Now comes a time when we will start to see what changes were temporary and which ones will become part of the new process, but one thing is certain, we will not be going back to where we were pre-pandemic.
Abstract licence: CC BY
References2
- 1.
1 more reference, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.